SCHEMBL6010124

SCHEMBL6010124

COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)C(O)CC1(C(N)=O)CNC1

nearest known ligand 0.71

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
EGFR P00533 20/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6008927 0.93 EGFR (0.69) EGFR
SCHEMBL5398418 0.93 EGFR (0.70) EGFR
SCHEMBL6008992 0.89 EGFR (0.74) EGFR
SCHEMBL6010022 0.86 EGFR (0.68) EGFR
SCHEMBL4448863 0.86 EGFR (0.85) EGFR
Hydrochloric Acid SCHEMBL4445060 0.85 EGFR (0.84) EGFR
SCHEMBL6009153 0.85 EGFR (0.70) EGFR
SCHEMBL6009605 0.84 EGFR (0.69) EGFR
SCHEMBL5405797 0.84 EGFR (0.69) EGFR
SCHEMBL6010141 0.83 EGFR (0.72) EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1713781-A1 QUINAZOLINE DERIVATIVES AstraZeneca AB (SE) 2006-10-25 EP disclosed
WO-2005075439-A1 QUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2005-08-18 WO disclosed